1. Guest editorial: prophylaxis and treatment of relapse after allogeneic hematopoietic stem cell transplantation

   • Daigo Hashimoto

   Progress in Hematology 11 July 2022 Pages: 307 - 308

2. Anti-programmed cell death-1 monoclonal antibody therapy before or after allogeneic hematopoietic cell transplantation for classic Hodgkin lymphoma: a literature review

   • Ayumu Ito
   • Sung-Won Kim
   • Takahiro Fukuda

   Progress in Hematology 02 June 2022 Pages: 309 - 314

3. Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation

   • Xing-yu Cao
   • Jing-jing Li
   • Kai-yan Liu

   Progress in Hematology 23 June 2022 Pages: 315 - 329

4. Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment

   • Firas Kreidieh
   • Iman Abou Dalle
   • Ali Bazarbachi

   Progress in Hematology 16 July 2022 Pages: 330 - 340

5. FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation

   • Francesca Biavasco
   • Robert Zeiser

   Progress in Hematology Open access 23 April 2022 Pages: 341 - 350

   

6. FLT3-targeted treatment for acute myeloid leukemia

   • Yasuyuki Arai
   • SungGi Chi
   • Masamitsu Yanada

   Review Article 09 May 2022 Pages: 351 - 363

7. Peripartum management of hereditary thrombophilia: results of primary surveillance in Japan

   • Takao Kobayashi
   • Kazuko Sugiura
   • Eriko Morishita

   Original Article 12 May 2022 Pages: 364 - 371

   

8. Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era

   • Jia Jin
   • Ailing Gui
   • Qunling Zhang

   Original Article 10 May 2022 Pages: 372 - 380

   

9. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

   • Juan-Manuel Sancho
   • Ana Marín-Niebla
   • Eva Rubio-Azpeitia

   Original Article Open access 13 May 2022 Pages: 381 - 392

   

10. Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia

    • Shuichi Mizuta
    • Tomotaka Ugai
    • Shinichi Kako

    Original Article 10 May 2022 Pages: 393 - 400

    

11. Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine–bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma

    • Anastasia Beynarovich
    • Kirill Lepik
    • Boris Afanasyev

    Original Article 05 May 2022 Pages: 401 - 410

    

12. MEdical Database AnaLysIS of Japanese multiple myeloma patienTs with apheresis #2 (MEDALIST-2): the impact of plerixafor use on costs and healthcare resources during mobilization and stem cell transplantation

    • Shinsuke Iida
    • Tadao Ishida
    • Takanori Teshima

    Original Article 13 May 2022 Pages: 411 - 422

    

13. Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy

    • Takuji Yoshimura
    • Shoko Furukawa
    • Keiji Nogami

    Original Article 03 May 2022 Pages: 423 - 433

    

14. A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial

    • Rintaro Ono
    • Kenichi Sakamoto
    • on behalf of The HLH/LCH committee members of the Japan Children’s Cancer Group

    Original Article 06 May 2022 Pages: 434 - 441

    

15. Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis

    • Patryk Sobieralski
    • Maria Bieniaszewska
    • Jan Maciej Zaucha

    Case Report 16 April 2022 Pages: 442 - 445

    

16. Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis

    • Kumi Nakazaki
    • Mina Yoshida
    • Mineo Kurokawa

    Case Report 30 March 2022 Pages: 446 - 452

    

17. Feasibility of ovarian stimulation for fertility preservation during and after blinatumomab treatment for Ph-negative B-cell acute lymphoblastic leukemia

    • Yusuke Tashiro
    • Junya Kanda
    • Akifumi Takaori-Kondo

    Case Report 14 March 2022 Pages: 453 - 458